Jie-Dan Mu Selected Research

Percutaneous Collagen Induction

7/2022	[Practical value and thought on "co-regulation of body and mind" in treatment of post-stroke spasticity with acupuncture].
1/2022	Acupuncture improves the structure of spastic muscle and decreases spasticity by enhancing GABA, KCC2, and GABAAγ2 in the brainstem in rats after ischemic stroke.
1/2022	Acupuncture Alleviates Menstrual Pain in Rat Model via Suppressing Eotaxin/CCR3 Axis to Weak EOS-MC Activation.
1/2021	Anti-spastic effect induced by waggle needling correlates with KCC2-GABAA pathway in post-stroke spasticity rats.
11/2020	[Perpendicular and transverse needling of "Sanyinjiao" (SP6) relieves abdominal pain by regulating arginine vasopressin and its receptor expression levels in uterus and hypothalamus in cold-stasis type dysmenorrhea rats].
10/2020	Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid.
1/2020	Comparison of the immediate analgesic effect of perpendicular needling and transverse needling at SP6 in patients with primary dysmenorrhea: Study protocol for a randomized controlled trial.
12/2019	[Analysis of the significance of kinetic needling in the treatment of spasm].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie-Dan Mu Research Topics

Disease

5	Muscle Spasticity (Spastic) 07/2022 - 10/2020
5	Stroke (Strokes) 07/2022 - 10/2020
5	Dysmenorrhea (Menstrual Pain) 03/2022 - 01/2020
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Ischemic Stroke 01/2022 - 01/2022
2	Pain (Aches) 01/2022 - 11/2020
2	Infarction (Infarctions) 01/2021 - 10/2020
2	Visceral Pain 01/2021 - 11/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Abnormal Reflex (Hyperreflexia) 01/2022
1	Abdominal Pain (Pain, Abdominal) 11/2020
1	Cerebral Infarction 10/2020
1	Ischemia 10/2020
1	Brain Ischemia (Cerebral Ischemia) 10/2020
1	Spasm (Spasms) 12/2019

Drug/Important Bio-Agent (IBA)

3	salicylhydroxamic acid (SHAM)IBA 04/2022 - 10/2020
3	gamma-Aminobutyric Acid (GABA)IBA 01/2022 - 10/2020
2	Aminobutyrates (Aminobutyric Acid)IBA 01/2022 - 10/2020
2	Analgesics (Analgesic Drugs)IBA 11/2020 - 01/2020
1	Excitatory Amino AcidsIBA 04/2022
1	Adenosine Triphosphatases (ATPase)IBA 04/2022
1	Glutamic Acid (Glutamate)FDA Link 04/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	ChemokinesIBA 01/2022
1	CCR3 ReceptorsIBA 01/2022
1	Oxytocin (Pitocin)FDA LinkGeneric 11/2020
1	estradiol 3-benzoate (estradiol benzoate)IBA 11/2020
1	Arginine Vasopressin (Argipressin)IBA 11/2020
1	triphenyltetrazoliumIBA 10/2020
1	Baclofen FDA LinkGeneric 10/2020
1	Transaminases (Aminotransferases)IBA 10/2020
1	Therapeutic UsesIBA 10/2020

Therapy/Procedure

8	Percutaneous Collagen Induction 07/2022 - 12/2019
2	Acupuncture Points (Acupuncture Point) 07/2022 - 12/2019
1	Sutures (Suture) 04/2022
1	Moxibustion 03/2022
1	Complementary Therapies (Alternative Medicine) 01/2022
1	Acupuncture Analgesia 01/2022
1	Therapeutics 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Subcutaneous Injections 11/2020